rs10477307

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_181675.4(PPP2R2B):​c.71-2431C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.238 in 152,054 control chromosomes in the GnomAD database, including 5,504 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.24 ( 5504 hom., cov: 32)

Consequence

PPP2R2B
NM_181675.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.667

Publications

3 publications found
Variant links:
Genes affected
PPP2R2B (HGNC:9305): (protein phosphatase 2 regulatory subunit Bbeta) The product of this gene belongs to the phosphatase 2 regulatory subunit B family. Protein phosphatase 2 is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. The B regulatory subunit might modulate substrate selectivity and catalytic activity. This gene encodes a beta isoform of the regulatory subunit B55 subfamily. Defects in this gene cause autosomal dominant spinocerebellar ataxia 12 (SCA12), a disease caused by degeneration of the cerebellum, sometimes involving the brainstem and spinal cord, and in resulting in poor coordination of speech and body movements. Multiple alternatively spliced variants, which encode different isoforms, have been identified for this gene. The 5' UTR of some of these variants includes a CAG trinucleotide repeat sequence (7-28 copies) that can be expanded to 55-78 copies in cases of SCA12. [provided by RefSeq, Jul 2016]
PPP2R2B Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 12
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.436 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_181675.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPP2R2B
NM_181675.4
MANE Select
c.71-2431C>T
intron
N/ANP_858061.3
PPP2R2B
NM_181674.3
c.269-2431C>T
intron
N/ANP_858060.2
PPP2R2B
NM_001271900.2
c.245-2431C>T
intron
N/ANP_001258829.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPP2R2B
ENST00000394411.9
TSL:2 MANE Select
c.71-2431C>T
intron
N/AENSP00000377933.3
PPP2R2B
ENST00000394414.5
TSL:1
c.269-2431C>T
intron
N/AENSP00000377936.1
PPP2R2B
ENST00000394409.7
TSL:1
c.71-2431C>T
intron
N/AENSP00000377931.4

Frequencies

GnomAD3 genomes
AF:
0.237
AC:
36078
AN:
151936
Hom.:
5481
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.441
Gnomad AMI
AF:
0.141
Gnomad AMR
AF:
0.192
Gnomad ASJ
AF:
0.107
Gnomad EAS
AF:
0.264
Gnomad SAS
AF:
0.166
Gnomad FIN
AF:
0.150
Gnomad MID
AF:
0.123
Gnomad NFE
AF:
0.150
Gnomad OTH
AF:
0.204
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.238
AC:
36142
AN:
152054
Hom.:
5504
Cov.:
32
AF XY:
0.236
AC XY:
17534
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.441
AC:
18268
AN:
41434
American (AMR)
AF:
0.192
AC:
2931
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.107
AC:
371
AN:
3468
East Asian (EAS)
AF:
0.264
AC:
1361
AN:
5156
South Asian (SAS)
AF:
0.165
AC:
792
AN:
4798
European-Finnish (FIN)
AF:
0.150
AC:
1591
AN:
10594
Middle Eastern (MID)
AF:
0.109
AC:
32
AN:
294
European-Non Finnish (NFE)
AF:
0.150
AC:
10227
AN:
67990
Other (OTH)
AF:
0.209
AC:
441
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1257
2513
3770
5026
6283
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
354
708
1062
1416
1770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.178
Hom.:
5405
Bravo
AF:
0.253
Asia WGS
AF:
0.233
AC:
812
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.29
DANN
Benign
0.21
PhyloP100
-0.67
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10477307; hg19: chr5-146083136; API